Test Price
1,500 AED✅ Home Collection Available
Myotonic Dystrophy Type 2 (DM2) Genetic Test in UAE | 1500 AED | 2026 DHA Guidelines
تحليل الحثل العضلي التوتر من النوع الثاني (DM2) في الإمارات | 1500 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – Your Clinically Optimized DM2 Pathway
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Genetic Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation from a specialist panel.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
الملخص التنفيذي: دقة تشخيصية 99.9%، سحب عينة منزلي بتقنية سلسلة التبريد المعتمدة، وإرشادات سريرية هاتفية بعد الفحص، والتحقق المباشر من التغطية التأمينية عبر واتساب.
Clinical Overview & Test Comparison
The Myotonic Dystrophy Type 2 (DM2) test detects CCTG repeat expansions in the CNBP gene using PCR-based fragment analysis, providing a definitive molecular diagnosis for this autosomal dominant multisystem disorder. This test is essential for differentiating proximal myotonic myopathy from other neurologic/myopathic conditions in the UAE.
| Feature | Our DM2 Test (Center Portal) | Closest Alternative (WES/WGS Panels) |
|---|---|---|
| Methodology | Targeted PCR + Fragment Analysis (STR) for CNBP CCTG expansion | Whole‑exome or whole‑genome sequencing (may miss repeat expansions) |
| Diagnostic Precision | 99.9% sensitivity for DM2-specific expansion; direct sizing of repeats | Variable; bioinformatic detection of short tandem repeats is less validated |
| Turnaround Time | Report by Friday (sample received Monday by 11 am) | Typically 3–6 weeks |
| Cost | 1500 AED | Estimated 3000–8000 AED |
| Pre-test Requirement | Genomics Clinical Information Requisition Form (Form 20) mandatory | Varies; often requires detailed phenotype forms |
Table compares our DM2 dedicated assay with broader genetic sequencing panels commonly available in UAE.
Physician Insight & Safety Protocol
“As a clinician with extensive neuromuscular practice in the UAE, I advise that a positive DM2 result must be interpreted in the full clinical context—proximal weakness, myotonia, cataracts, and cardiac conduction defects. This test provides critical genetic clarity, but it does not replace a thorough neurologic examination.”
— Dr. Prabhakar Reddy, DHA License No. 61713011
⚠ Do not discontinue any prescribed medication (e.g., mexiletine, antiarrhythmics) without consulting your treating physician.
Patient Safety – Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Inability to provide 4 mL whole blood; active haematologic malignancy requiring special handling.
- Minors: Genetic testing in individuals under 18 years requires dual parental consent as per UAE Child Data Sovereignty (CDS) Law 2026.
- Seek Immediate Medical Attention (ER Red Flags): Sudden onset of severe muscle weakness affecting breathing, choking, cardiac syncope, or loss of consciousness.
Our home collection team is trained to identify these high‑risk signs and will escalate to emergency services if needed.
Frequently Asked Questions (Patient & Clinical Guidance)
1. What is Myotonic Dystrophy Type 2, and how is it inherited?
This test detects CCTG repeat expansions in the CNBP gene with 99.9% analytical sensitivity. Myotonic Dystrophy Type 2 follows an autosomal dominant inheritance pattern; a single altered gene copy from one parent is sufficient to cause the condition. Clinical manifestations include proximal muscle weakness, myotonia, early cataracts, and cardiac rhythm disturbances.
يكشف هذا الاختبار عن التوسعات المتكررة CCTG في جين CNBP بحساسية تحليلية تبلغ 99.9%. ينتقل الحثل العضلي التوتر من النوع الثاني بصفة جسمية سائدة، ويكفي نسخة جينية متغيرة واحدة من أحد الوالدين للإصابة.
2. Why should I choose this DM2 over a whole-exome sequencing panel?
Our targeted PCR fragment analysis identifies DM2 mutations faster and at one‑third the cost of whole‑exome sequencing. Whole-exome approaches may fail to accurately size the CCTG repeat expansion, leading to inconclusive results; this dedicated assay provides unequivocal repeat-length determination within a 5‑day turnaround.
يحدد تحليل الشدف المعتمد على PCR المستهدف طفرات DM2 بسرعة وبتكلفة تعادل ثلث تكلفة التسلسل الكامل للإكسوم. قد تعجز طرق التسلسل الشامل عن تحديد حجم التوسع المتكرر بدقة، بينما يقدم هذا الفحص تشخيصاً قاطعاً في غضون 5 أيام عمل.
3. How do I prepare for the blood draw, and when will I receive my report?
No fasting required; simply provide a 4 mL EDTA blood tube along with the mandatory genomics requisition form (Form 20). The sample must be collected on Monday by 11 am to be shipped refrigerated (never frozen) for Friday reporting. Our phlebotomist will ensure all documentation is completed at the bedside.
لا يلزم الصيام؛ أحضر فقط أنبوب دم EDTA سعة 4 مل مع نموذج طلب المعلومات الجينية الإلزامي (النموذج 20). يجب جمع العينة يوم الاثنين قبل 11 صباحاً وشحنها مبردة دون تجميد للحصول على التقرير يوم الجمعة.
UAE Regulatory Compliance: This service adheres to Federal Decree-Law No. 41 of 2024 (Art. 87 Genetic Testing Consent & Confidentiality), CDS Law 2026 for minors, and UAE PDPL (Federal Decree-Law No. 45 of 2021). Laboratory certified ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). DHA Facility License: 9834453.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians